Five things for pharma marketers to know: Monday, February 8, 2016

PhRMA and BIO ramp up ad spend for presidential election year; Super Bowl Sunday features three pharma ads; Pfizer solidifies leadership team

Celebrity drug ads: Opportunity or PR disaster?

Tapping celebrities for brand or awareness campaigns ensures a high degree of attention, but such arrangements come with concerns that "regular" ones do not.

The best and worst celebrity pharma moments

Heaven knows the industry is itself to blame for some of the dopier recurring imagery in its DTC spots, like models clad in white linen ...

Taking a Tinder Approach to the Agency-Client Relationship

Taking a Tinder Approach to the Agency-Client Relationship

Imagine if you could choose your agency partners based on attributes most appealing to you. With a swipe to the right or left, you could secure them a roster position or doom them to languish in procurement.

50 celebrity healthcare endorsements

50 celebrity healthcare endorsements

Here's Jon Bon Jovi for Advil, Arnold Palmer for Xarelto and 48 more past and present celebrity endorsements of drugs, healthcare products and disease awareness campaigns.

15 unexpected Twitter responses to the "Who Pneu?" campaign

15 unexpected Twitter responses to the "Who Pneu?" campaign

Celebrity success or fail? Here's what the American Lung Association, Pfizer and Tim Daly likely did not see coming when they joined forces to raise awareness about pneumococcal pneumonia.

Five things for pharma marketers to know: Friday, February 5, 2016

Five things for pharma marketers to know: Friday, February 5, 2016

Johnson & Johnson collaborates with biotech on diabetes stem-cell treatment; the FDA warms up to Remicade biosimilar; Woodcock warns about biosimilar backlog

Why Gathering Health Economic Data for Cancer Drugs is Now Essential

Why Gathering Health Economic Data for Cancer Drugs is Now Essential

Health economic and outcomes research datasets have rarely been integral to product development and communication plans.

Ascension Health ups Ragone to chief marcomms officer

Ascension Health ups Ragone to chief marcomms officer

The Ketchum veteran joined the nonprofit healthcare system in mid-2014.

House Oversight committee upbraids Turing, Valeant execs

House Oversight committee upbraids Turing, Valeant execs

A House lawmaker called pricing strategies used by Turing and Valeant "repulsive."

Burcin departs Havas network for Klick Health in senior-staffing push

Burcin departs Havas network for Klick Health in senior-staffing push

Burcin's charge is to keep momentum going at the indie agency, known for placing ice-cream carts outside of rival agencies and other recruiting tactics.

Five things for pharma marketers to know: Thursday, February 4, 2016

Five things for pharma marketers to know: Thursday, February 4, 2016

Valeant to push for changes to financial-assistance rules; House to hold hearing on drug-pricing practices; FDA committee says Lundbeck can add information to leaflet

4 Industry Execs Examine the State of Physician-Rep Access

4 Industry Execs Examine the State of Physician-Rep Access

Recent polls paint a mixed picture of physicians' willingness to see pharma sales reps. What gives? Are no-see docs up or down, and what's behind the dissonant findings?

McCann Torre Lazur names new president

McCann Torre Lazur names new president

After Bill McEllen's departure, the company promoted Mark Willmann to lead the agency.

Johnson & Johnson comms leader stepping down

Johnson & Johnson comms leader stepping down

FitzPatrick is departing the company as it evaluates its 150 agency partnerships.

Making the Case for the Value of Co-pay Cards

Making the Case for the Value of Co-pay Cards

Now that payers are locking in discounts at launch from drugmakers, where do co-pay cards fit in the marketing mix?

Medical Advertising Hall of Fame inductees of 2016

Medical Advertising Hall of Fame inductees of 2016

A pharma research forefather. An agency builder. A "guy you wanted in the room." These Medical Advertising Hall of Fame inductees are a professionally diverse and richly worthy trio.

Five things for pharma marketers to know: Wednesday, February 3, 2016

Five things for pharma marketers to know: Wednesday, February 3, 2016

Seven potential blockbusters set to launch in 2016; Amarin case may lead to 'misleading' marketing; Valeant, Turing raised prices to meet preset targets

Agency Spotlight


Email Newsletters